Compare Five9 Inc (FIVN) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Five9 Inc vs Vir Biotechnology Inc. Common Stock — how do they compare? Five9 Inc trades at $33.37 (market cap $2.65B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Five9 Inc is the larger of the two by market cap, and Five9 Inc is more actively traded (971,747 versus 1,782,836). Which is the better fit depends on your goals — on Pluang, investors hold Five9 Inc for 72 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| FIVN | VIR | |
|---|---|---|
Market Cap | $2.65B | $1.80B |
Volume | 971,747 | 1,782,836 |
Sector | Technology | Health |
52-Week High | $38.65 | $11.78 |
52-Week Low | $13.61 | $5.12 |
Typical Hold Time | 72 Days | 0 Days |
Enterprise Value | $2.80B | $1.36B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Five9 (FIVN) trades at $33.08, down 7.26% today amid recent volatility, though the stock remains near its 52-week high of $39.55. The company shows strong fundamental momentum with three consecutive quarterly earnings beats and accelerating AI revenue growth reaching 78% year-over-year. Technical indicators suggest a bullish trend with moving averages supporting upside potential, while RSI levels remain neutral. Five9 maintains leadership in the contact center-as-a-service market with improving profitability margins.
The outlook remains positive with analyst consensus favoring Buy ratings (61%) and a $34 price target representing 3% upside. Key opportunities include AI revenue expansion and market leadership, while risks involve insider selling activity and competitive pressures in the CCaaS space. The company's transition to profitability and strong subscription growth support continued investor interest.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Five9 Inc
Five9 provides cloud-native contact center software that enables digital customer service, sales, and marketing engagement. The company's Virtual Contact Center platform combines core telephony functionality, omnichannel engagement capabilities, and various software modules into a unified cloud contact-center-as-a-service, or CCaaS, platform. Five9's artificial intelligence and automation portfolio supplements and enhances the firm's core CCaaS offerings, including solutions for digital self-service, agent assist technology, and workflow automation. Five9 also offers workforce optimization products that optimize call center efficiency through workforce management solutions, manage interaction quality, and track agent performance.
Read more on FIVN →About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →
